ICH Q9(R1) Quality Risk Management Revision – Public Consultation

被引：0
|
作者：
Pluta, Paul L.
机构：
来源：
Journal of Validation Technology | 2021年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 39 条
  • [11] Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice
    Bohdana Ratitch
    James Bell
    Craig Mallinckrodt
    Jonathan W. Bartlett
    Niti Goel
    Geert Molenberghs
    Michael O’Kelly
    Pritibha Singh
    Ilya Lipkovich
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 324 - 341
  • [12] Clinical and Statistical Perspectives on the ICH E9(R1) Estimand Framework Implementation
    Ionan, Alexei C.
    Paterniti, Miya
    Mehrotra, Devan, V
    Scott, John
    Ratitch, Bohdana
    Collins, Sylva
    Gomatam, Shanti
    Nie, Lei
    Rufibach, Kaspar
    Bretz, Frank
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (03): : 554 - 559
  • [13] Estimands in observational studies: Some considerations beyond ICH E9 (R1)
    Li, Heng
    Wang, Chenguang
    Chen, Wei-Chen
    Lu, Nelson
    Song, Changhong
    Tiwari, Ram
    Xu, Yunling
    Yue, Lilly Q.
    PHARMACEUTICAL STATISTICS, 2022, 21 (05) : 835 - 844
  • [14] Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice
    Ratitch, Bohdana
    Bell, James
    Mallinckrodt, Craig
    Bartlett, Jonathan W.
    Goel, Niti
    Molenberghs, Geert
    O'Kelly, Michael
    Singh, Pritibha
    Lipkovich, Ilya
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 324 - 341
  • [15] Practice Quality System Management in an Innovative Pharmaceutical Enterprise Implementation of the directives ICH Q 9 and Q 10
    Gyra, Annett-Kathrin
    Freitag, Eckhard
    Geisler, Viktor
    PHARMAZEUTISCHE INDUSTRIE, 2009, 71 (09): : 1621 - 1624
  • [16] Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)
    Patricia Mercier-Letondal
    Chrystel Marton
    Yann Godet
    Jeanne Galaine
    Journal of Translational Medicine, 19
  • [17] ICH E14 Q & A (R1) document: perspectives on the updated recommendations on thorough QT studies
    Shah, Rashmi R.
    Morganroth, Joel
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (04) : 959 - 965
  • [18] Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)
    Mercier-Letondal, Patricia
    Marton, Chrystel
    Godet, Yann
    Galaine, Jeanne
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [19] Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice
    Mallinckrodt, C. H.
    Bell, J.
    Liu, G.
    Ratitch, B.
    O'Kelly, M.
    Lipkovich, I
    Singh, P.
    Xu, L.
    Molenberghs, G.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 353 - 364
  • [20] Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice
    C. H. Mallinckrodt
    J. Bell
    G. Liu
    B. Ratitch
    M. O’Kelly
    I. Lipkovich
    P. Singh
    L. Xu
    G. Molenberghs
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 353 - 364
1234